Eli Lilly's (LLY.N), opens new tab approved blood cancer therapy Jaypirca has demonstrated its ability to delay disease progression in patients who had not received prior treatment, as evidenced by a late-stage study, positioning it as a potential
Alcon, a prominent leader in eye care committed to enhancing vision, has recently unveiled the UNITY Vitreoretinal Cataract System (VCS) and the UNITY Cataract System (CS) in India.
Sanjivani Paranteral Limited's subsidiary, SPL Infusion Pvt. Ltd., has initiated commercial production at its newly established IV Fluid Infusion Plant located in Pune, Maharashtra, effective from 6th September 2025, following the acquisition of the
Akums Drugs & Pharmaceuticals Ltd. has said that its Hormonal Manufacturing Plant has received a Good Manufacturing Practice (GMP) Certificate from the (BEAEU)
Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Singapore, has signed an agreement with Kenox Pharmaceuticals, a high-growth contract development and manufacturing organization with a focus on..
Cipla has officially launched HUENA (Methenamine Hippurate), India's first non-antibiotic UTI drug. This is especially timely, as UTIs are the second most common reason for antibiotic use in India, with the number of cases nearly doubling over the...
Takeda got an approval from the U.S. Food and Drug Administration (FDA) for the additional Biologics License Application (BLA) for VONVENDI
The Indian healthcare industry is increasingly recognizing artificial intelligence (AI) as a crucial strategic element, facilitating advanced treatments and promoting systemic efficiency throughout the sector.
Argo Biopharmaceutical, a biotechnology firm in the clinical stage that specializes in the development of next-generation siRNA therapeutics, has announced the establishment of an additional strategic partnership with Novartis concerning several
Mankind Pharma, India's fourth largest pharma company, has received approval from CDSCO to conduct a phase 1 clinical trial for its new JAK-1 inhibitor, MKP11093. The orally available drug molecule, which has been developed at Mankind Research...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")